Literature DB >> 12736395

Neonatal hyperbilirubinemia in Japanese neonates: analysis of the heme oxygenase-1 gene and fetal hemoglobin composition in cord blood.

Masayo Kanai1, Kazuhiro Akaba, Ayako Sasaki, Michihiko Sato, Teruo Harano, Shigeki Shibahara, Hirohisa Kurachi, Tadashi Yoshida, Kiyoshi Hayasaka.   

Abstract

Neonatal hyperbilirubinemia is frequent and severe in Japanese infants. Although the G71R mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene is associated with severe neonatal hyperbilirubinemia in this population, it accounts for only half of the neonates with severe hyperbilirubinemia. It was suggested that increased bilirubin production would also be associated with severe neonatal hyperbilirubinemia in Japanese infants. To elucidate the genetic factors causing severe hyperbilirubinemia in these patients, we studied two notable factors associated with bilirubin production: heme oxygenase-1, a key enzyme of heme metabolism, and fetal Hb composition, a factor possibly associated with heme load in neonates. We first determined the sequences of promoter and all coding regions of the heme oxygenase-1 gene in Japanese neonates who had undergone phototherapy, but found no mutation except for the polymorphic (GT)n repeats in the promoter region. These repeats modulate the transcription of the heme oxygenase-1 gene, and the longer repeat sequences are known to reduce the transcription. We detected a significant difference in the allele frequencies of each number of (GT)n repeats between Japanese and German populations. However, we could not find a relation between those polymorphisms and neonatal hyperbilirubinemia. We next analyzed the state of Hb switching of the gamma- to beta-globin chain and the phenotype of gamma-globin chain isoforms in cord blood. We found no relation between fetal Hb composition and neonatal hyperbilirubinemia. Further studies are required to elucidate genetic or environmental factors in neonatal hyperbilirubinemia in Japanese infants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736395     DOI: 10.1203/01.PDR.0000072329.56635.35

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.

Authors:  Hiroko Sato; Toshihiko Uchida; Kentaro Toyota; Tomohiro Nakamura; Gen Tamiya; Miyako Kanno; Taeko Hashimoto; Masashi Watanabe; Kuraaki Aoki; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

Review 2.  Heme oxygenase-1 promoter polymorphisms: do they modulate neonatal hyperbilirubinemia?

Authors:  M Kaplan; R J Wong; D K Stevenson
Journal:  J Perinatol       Date:  2017-02-16       Impact factor: 2.521

3.  Heme oxygenase-1 gene variants and hyperbilirubinemia risk in North Indian newborns.

Authors:  Pankaj Kumar Tiwari; Amanpreet Sethi; Sriparna Basu; Rajiva Raman; Ashok Kumar
Journal:  Eur J Pediatr       Date:  2013-07-23       Impact factor: 3.183

4.  Genetic polymorphisms of heme-oxygenase 1 (HO-1) may impact on acute kidney injury, bronchopulmonary dysplasia, and mortality in premature infants.

Authors:  David J Askenazi; Brian Halloran; Neha Patil; Susan Keeling; Behtash Saeidi; Rajesh Koralkar; Namasivayam Ambalavanan
Journal:  Pediatr Res       Date:  2015-03-09       Impact factor: 3.756

5.  HMOX1 gene promoter polymorphism is not associated with coronary artery disease in Koreans.

Authors:  Seong Woo Han; Wonkeun Song; Han-Sung Kim; Kyu-Sung Shin; Heejung Kang; Hyoun Chan Cho; Chang-Seok Ki; Min-Jeong Park
Journal:  Ann Lab Med       Date:  2014-08-21       Impact factor: 3.464

6.  Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.

Authors:  Yi-Hao Weng; Ya-Wen Chiu; Shao-Wen Cheng; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2016-08-24       Impact factor: 2.125

Review 7.  Two Faces of Heme Catabolic Pathway in Newborns: A Potential Role of Bilirubin and Carbon Monoxide in Neonatal Inflammatory Diseases.

Authors:  Wiktoria Osiak; Sławomir Wątroba; Lucyna Kapka-Skrzypczak; Jacek Kurzepa
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

Review 8.  The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.

Authors:  Ruka Nakasone; Mariko Ashina; Shinya Abe; Kenji Tanimura; Hans Van Rostenberghe; Kazumichi Fujioka
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.